4,4'-Difluoro-2,2'-bipyridine, 97.0%, 50mg

3-Benzyloxypropyl(triphenyl)phosphonium bromide, 98+%, 100g

ROTI®Cell DPBS, 500 ml

2H-Pyran-2-one, 6-[2-(1,3-benzodioxol-5-yl)ethyl]-5,6-dihydro-4-methoxy-, (6S)-, 90%, 25mg

(1R,3S,E)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5S,E)-5-Cyclopropyl-5-hydroxypent-3-en-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol, 98%, 1g

(2,2-dimethylcyclopropyl)methanol, 95.0%, 5g

Methyl 4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 97%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-isopropylphenyl)propanoic acid, 98%, 1g

(2E)-3-(3-fluorophenyl)-1-(3-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

Morroniside, 98%, 100mg

MK2 INHIBITOR, 98.0%, 1mg

TUCIDINOSTAT, 95%, 10mg

3-(2-Chloro-phenyl)-3-oxo-propionic acid ethylester, 95.0%, 5g